PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma
PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma
复制标题
DOI:
10.1111/j.1349-7006.2009.01292.x
复制
发表时间:
2009-11-01
期刊:
影响因子:
5.7
通讯作者:
Mokdad-Gargouri, Raja
中科院分区:
文献类型:
--
作者:
Fendri, Ali;Khabir, Abdelmajid;Mokdad-Gargouri, Raja
PI3Ks (phosphatidylinositol 3‐kinases) are lipid kinases that regulate signalling pathways involved in cell proliferation, motility, and adhesion. Somatic mutations and amplification of thePIK3CAgene have been reported in various types of human cancers. However, little is known about the frequency and prognosis role ofPIK3CAactivation in nasopharyngeal carcinoma (NPC). This study was conducted with the aim to screen forPIK3CAmutations in the two hot spot regions (exons 9 and 20) and to investigate for thePIK3CAgene amplification combined with the expression analysis of the phosphorylated Akt (pAkt). We showed that among 88 specimens, none had mutation in the helical domain (exon 9) and only one (1.13%) had mutation in the kinase domain (exon 20). On the other hand,PIK3CAgene amplification was found in 21.6% of cases and was strongly associated with distant metastasis (P= 0.002), lymph node involvement (P= 0.032), and advanced tumor stage (P< 0.001). Moreover, patients withPIK3CAcopy number gain have a significant reduced overall survival time (P log rank = 0.02). We concluded thatPIK3CAgene amplification is frequent in NPC and occurs in the advanced stage of NPC. Moreover, our finding emphasizes the association ofPIK3CAgene amplification with worse prognosis in nasopharyngeal carcinoma. (Cancer Sci2009); 00: 000–000)